- Home
- CULP vs OTLK Comparison
CULP vs OTLK Comparison
Compare CULP & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CULP
- OTLK
- Stock Information
- Founded
- CULP 1972
- OTLK 2010
- Country
- CULP United States
- OTLK United States
- Employees
- CULP N/A
- OTLK N/A
- Industry
- CULP Textiles
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CULP Consumer Discretionary
- OTLK Health Care
- Exchange
- CULP Nasdaq
- OTLK Nasdaq
- Market Cap
- CULP 50.9M
- OTLK 48.3M
- IPO Year
- CULP N/A
- OTLK 2016
- Fundamental
- Price
- CULP $3.97
- OTLK $1.71
- Analyst Decision
- CULP
- OTLK Strong Buy
- Analyst Count
- CULP 0
- OTLK 5
- Target Price
- CULP N/A
- OTLK $9.60
- AVG Volume (30 Days)
- CULP 14.7K
- OTLK 823.9K
- Earning Date
- CULP 06-30-2025
- OTLK 08-13-2025
- Dividend Yield
- CULP N/A
- OTLK N/A
- EPS Growth
- CULP N/A
- OTLK N/A
- EPS
- CULP N/A
- OTLK 0.83
- Revenue
- CULP $213,993,000.00
- OTLK N/A
- Revenue This Year
- CULP N/A
- OTLK N/A
- Revenue Next Year
- CULP $5.99
- OTLK $379.84
- P/E Ratio
- CULP N/A
- OTLK $2.06
- Revenue Growth
- CULP N/A
- OTLK N/A
- 52 Week Low
- CULP $3.42
- OTLK $0.87
- 52 Week High
- CULP $6.85
- OTLK $9.25
- Technical
- Relative Strength Index (RSI)
- CULP 46.03
- OTLK 46.49
- Support Level
- CULP $3.82
- OTLK $1.65
- Resistance Level
- CULP $4.01
- OTLK $1.97
- Average True Range (ATR)
- CULP 0.15
- OTLK 0.12
- MACD
- CULP -0.01
- OTLK -0.03
- Stochastic Oscillator
- CULP 37.78
- OTLK 10.94
About CULP Culp Inc.
Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.